CYCLOPHARM LIMITED ORDINARY (CYC) News
Latest articles and price-sensitive announcements with AI sentiment classification.
ASXAppointment of Non-Executive Director and Incoming Chair
other announcement
Resignation of Non-Executive Director John Wigglesworth
other announcement
CYC Secures Multi-Site Agreement with Northwestern Medicine
other announcement
Small CapsChange of Director's Interest Notice - JM
director_dealing announcement
Change of Director's Interest Notice - KB
director_dealing announcement
Change of Director's Interest Notice - JW
director_dealing announcement
Change of Director's Interest Notice - DA
director_dealing announcement
Change of Director's Interest Notice - DH
director_dealing announcement
Technegas US Footprint Expanding Across Four Regions
other announcement
Technegas Approved at the US National Institutes of Health
other announcement
Cyclopharm Successfully Completes A$14 million Placement
capital_raise announcement
CYC Unaudited Trading Update - Preliminary FY2025 Results
other announcement
COPD Study Leveraging Technegas and AI-Driven Lung Analysis
other announcement
Technegas Recognised in Updated Clinical Guideline
other announcement
Colombia Approval Marks 67th Country for Technegas
other announcement
Cyclopharm Bell Potter Healthcare Conference Presentation
other announcement
Cyclopharm Secures Maximum US Patent Extension for Technegas
other announcement